Induction of eosinophil apoptosis by hydrogen peroxide promotes the resolution of allergic inflammation

Cell Death and Disease

Volumn 6, Issue 2, 2015, Pages

  Reis, A C ^a   Alessandri, A L ^b   Athayde, R M ^a   Perez, D A ^a   Vago, J P ^a   Avila T V ^a   Ferreira, T P T ^c   De Arantes, A C S ^c   De Sa Coutinho D ^c   Rachid, M A ^a   Sousa, L P ^a   Martins, M A ^c   Menezes, G B ^a   Rossi, A G ^b   Teixeira, M M ^a   Pinho, V ^a  

^a FEDERAL UNIVERSITY OF MINAS GERAIS   (Brazil)

^b UNIVERSITY OF EDINBURGH   (United Kingdom)

^c INSTITUTO OSWALDO CRUZ   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

APOCYNIN; CHEMOKINE; CYTOKINE; GLYCOPROTEIN GP 91; HYDROGEN PEROXIDE; METHACHOLINE; OVALBUMIN; REACTIVE OXYGEN METABOLITE; SUPEROXIDE DISMUTASE;

AIRWAY RESISTANCE; ALLERGIC AIRWAY INFLAMMATION; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CELL COUNT; CELL INFILTRATION; CELL KINETICS; CONTROLLED STUDY; CYTOARCHITECTURE; EOSINOPHIL; FLUOROMETRY; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; INFLAMMATORY CELL; LUNG FUNCTION; LUNG PARENCHYMA; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; ANIMAL; ASTHMA; C57BL MOUSE; CELL LINE; CHEMICALLY INDUCED; CYTOLOGY; DRUG EFFECTS; IMMUNOLOGY; INFLAMMATION; LEUKOCYTE; LUNG; METABOLISM; PLEURISY; WESTERN BLOTTING;

MUS;

ANIMALS; APOPTOSIS; ASTHMA; BLOTTING, WESTERN; CELL LINE; EOSINOPHILS; HUMANS; HYDROGEN PEROXIDE; INFLAMMATION; LEUKOCYTES; LUNG; MALE; MICE; MICE, INBRED C57BL; PLEURISY; REACTIVE OXYGEN SPECIES;

EID: 84927586555     PISSN: None     EISSN: 20414889     Source Type: Journal    
DOI: 10.1038/cddis.2014.580     Document Type: Article

References (62)

1. Luna-Gomes T, Bozza PT, Bandeira-Melo C. Eosinophil recruitment and activation: the role of lipid mediators. Fronti Pharmacol 2013; 4: 27.
2. Rothenberg ME, Hogan SP. The eosinophil. Ann Rev Immunol 2006; 24: 147-174.
3. Holgate ST. The airway epithelium is central to the pathogenesis of asthma. Allergol Int 2008; 57: 1-10.
4. Felton JM, Lucas CD, Rossi AG, Dransfield I. Eosinophils in the lung-modulating apoptosis and efferocytosis in airway inflammation. Front Immunol 2014; 5: 302.
5. Kay AB. The role of T lymphocytes in asthma. Chem Immunol Allergy 2006; 91: 59-75.
6. Afshar R, Medoff BD, Luster AD. Allergic asthma: a tale of many T cells. Clin Exp Allergy 2008; 38: 1847-1857.
7. Nouri-Aria KT, Durham SR. Regulatory T cells and allergic disease. Inflamm Allergy Drug Targets 2008; 7: 237-252.
8. Jacobsen EA, Helmers RA, Lee JJ, Lee NA. The expanding role(s) of eosinophils in health and disease. Blood 2012; 120: 3882-3890.
9. Fulkerson PC, Rothenberg ME. Targeting eosinophils in allergy, inflammation and beyond. Nat Rev Drug Discov 2013; 12: 117-129.
10. Wilson SJ, Rigden HM, Ward JA, Laviolette M, Jarjour NN, Djukanovic R. The relationship between eosinophilia and airway remodelling in mild asthma. Clin Exp Allergy 2013; 112: 1342-1350.
11. Nair P. Anti-interleukin-5 monoclonal antibody to treat severe eosinophilic asthma. N Eng J Med 2014; 371: 1249-1251.
12. Duncan CJA, Lawrie A, Blaylock MG, Douglas JG,Walsh GM. Reduced eosinophil apoptosis in induced sputum correlates with asthma severity. Eur Respir J 2003; 22: 484-490.
13. Walsh GM. Eosinophil apoptosis: Mechanisms and clinical relevance in asthmatic and allergic inflammation. Brit J Haematol 2000; 111: 61-67.
14. Vignola AM, Chanez P, Chiappara G, Siena L, Merendino A, Reina C et al. Evaluation of apoptosis of eosinophils, macrophages, and T lymphocytes in mucosal biopsy specimens of patients with asthma and chronic bronchitis. J Allergy Clin Immunol 1999; 103: 563-573.
15. Gautier EL, Ivanov S, Lesnik P, Randolph GJ. Local apoptosis mediates clearance of macrophages from resolving inflammation in mice. Blood 2013; 122: 2714-2722.
16. Walsh GM. Eosinophil apoptosis and clearance in asthma. J Cell Death 2013; 6: 17-25.
17. Alessandri AL, Duffin R, Leitch AE, Lucas CD, Sheldrake TA, Dorward DA et al. Induction of eosinophil apoptosis by the cyclin-dependent kinase inhibitor AT7519 promotes the resolution of eosinophil-dominant allergic inflammation. PloS One 2011; 6: e25683.
18. Lopes F, Coelho FM, Costa VV, Vieira EL, Sousa LP, Silva TA et al. Resolution of neutrophilic inflammation by H2O2 in antigen-induced arthritis. Arthritis Rheum 2011; 63: 2651-2660.
19. Fialkow L, Wang Y, Downey GP. Reactive oxygen and nitrogen species as signaling molecules regulating neutrophil function. Free Radic Biol Med 2007; 42: 153-164.
20. Wartha F, Henriques-Normark B. ETosis: a novel cell death pathway. Sci Signal 2008; 1: pe25.
21. Sareila O, Kelkka T, Pizzolla A, Hultqvist M, Holmdahl R. NOX2 complex-derived ROS as immune regulators. Antioxid Redox Signal 2011; 15: 2197-2208.
22. Segal BH, Grimm MJ, Khan AN, Han W, Blackwell TS. Regulation of innate immunity by NADPH oxidase. Free Rad Biol Med 2012; 53: 72-80.
23. Gardiner GJ, Deffit SN, McLetchie S, Perez L, Walline CC, Blum JS. A Role for NADPH oxidase in antigen presentation. Front Immunol 2013; 4: 295.
24. Han W, Li H, Cai J, Gleaves LA, Polosukhin VV, Segal BH et al. NADPH oxidase limits lipopolysaccharide-induced lung inflammation and injury in mice through reduction-oxidation regulation of NF-kappaB activity. J Immunol 2013; 190: 4786-4794.
25. Stock P, Akbari O, Berry G, Freeman GJ, Dekruyff RH, Umetsu DT. Induction of T helper type 1-like regulatory cells that express Foxp3 and protect against airway hyper-reactivity. Nat Immunol 2004; 5: 1149-1156.
26. Noda H, Sakagami H, Kokubu F, Kurokawa M, Tokunaga H, Takeda M et al. Induction of apoptosis in human eosinophilic leukemic cell line (EOL-1). Int Arch Allergy Immunol 1997; 114(Suppl 1): 84-88.
27. Mayumi M. EoL-1, a human eosinophilic cell line. Leuk Lymphoma 1992; 7: 243-250.
28. Bezerra-Santos CR, Vieira-de-Abreu A, Vieira GC, Filho JR, Barbosa-Filho JM, Pires AL et al. Effectiveness of Cissampelos sympodialis and its isolated alkaloid warifteine in airway hyperreactivity and lung remodeling in a mouse model of asthma. Int Immunopharmacol 2012; 13: 148-155.
29. Kim SJ, Jung HJ, Hyun DH, Park EH, Kim YM, Lim CJ. Glutathione reductase plays an antiapoptotic role against oxidative stress in human hepatoma cells. Biochimie 2010; 92: 927-932.
30. Hussain S, Thomassen LC, Ferecatu I, Borot MC, Andreau K, Martens JA et al. Carbon black and titanium dioxide nanoparticles elicit distinct apoptotic pathways in bronchial epithelial cells. Part Fibre Toxicol 2010; 7: 10.
31. Fang WT, Li HJ, Zhou LS. Protective effects of prostaglandin E1 on human umbilical vein endothelial cell injury induced by hydrogen peroxide. Acta Pharmacologica Sinica 2010; 31: 485-492.
32. Zhang L, Jiang H, Gao X, Zou Y, Liu M, Liang Y et al. Heat shock transcription factor-1 inhibits H2O2-induced apoptosis via down-regulation of reactive oxygen species in cardiac myocytes. Mol Cell Biochem 2011; 347: 21-28.
33. Kankaanranta H, Giembycz MA, Barnes PJ, Haddad el B, Saarelainen S, Zhang X et al. Hydrogen peroxide reverses IL-5 afforded eosinophil survival and promotes constitutive human eosinophil apoptosis. Int Arch Allergy Immunol 2002; 127: 73-78.
34. Wedi B, Straede J, Wieland B, Kapp A. Eosinophil apoptosis is mediated by stimulators of cellular oxidative metabolisms and inhibited by antioxidants: involvement of a thiol-sensitive redox regulation in eosinophil cell death. Blood 1999; 94: 2365-2373.
35. Deng J, Wang X, Qian F, Vogel S, Xiao L, Ranjan R et al. Protective role of reactive oxygen species in endotoxin-induced lung inflammation through modulation of IL-10 expression. J Immunol 2012; 188: 5734-5740.
36. Zhang X, Moilanen E, Lahti A, Hamalainen M, Giembycz MA et al. Regulation of eosinophil apoptosis by nitric oxide: Role of c-Jun-N-terminal kinase and signal transducer and activator of transcription 5. J Allergy Clin Immunol 2003; 112: 93-101.
37. Pontin J, Blaylock MG, Walsh GM, Turner SW. Sputum eosinophil apoptotic rate is positively correlated to exhaled nitric oxide in children. Pediatr Pulmonol 2008; 43: 1130-1134.
38. Ilmarinen-Salo P, Moilanen E, Kankaanranta H. Nitric oxide induces apoptosis in GM-CSFtreated eosinophils via caspase-6-dependent lamin and DNA fragmentation. Pulm Pharmacol Ther 2010; 23: 365-371.
39. Ilmarinen-Salo P, Moilanen E, Kinnula VL, Kankaanranta H. Nitric oxide-induced eosinophil apoptosis is dependent on mitochondrial permeability transition (mPT), JNK and oxidative stress: apoptosis is preceded but not mediated by early mPT-dependent JNK activation. Respir Res 2012; 13: 73.
40. Ilmarinen P, Moilanen E, Kankaanranta H. Mitochondria in the center of human eosinophil apoptosis and survival. Int J Mol Sci 2014; 15: 3952-3969.
41. Matera MG, Calzetta L, Cazzola M. TNF-alpha inhibitors in asthma and COPD: we must not throw the baby out with the bath water. Pulm Pharmacol Ther 2010; 23: 121-128.
42. Yang M, Hogan SP, Mahalingam S, Pope SM, Zimmermann N, Fulkerson P et al. Eotaxin-2 and IL-5 cooperate in the lung to regulate IL-13 production and airway eosinophilia and hyperreactivity. J Allergy Clin Immunol 2003; 112: 935-943.
43. Klein A, Talvani A, Silva PM, Martins MA, Wells TN, Proudfoot A et al. Stem cell factorinduced leukotriene B4 production cooperates with eotaxin to mediate the recruitment of eosinophils during allergic pleurisy in mice. J Immunol 2001; 167: 524-531.
44. Kobayashi T, Iijima K, Kita H. Marked airway eosinophilia prevents development of airway hyper-responsiveness during an allergic response in IL-5 transgenic mice. J Immunol 2003; 170: 5756-5763.
45. Rosenberg HF, Phipps S, Foster PS. Eosinophil trafficking in allergy and asthma. J Allergy Clin Immunol 2007; 119: 1303-1310.
46. Yamaguchi Y, Hayashi Y, Sugama Y, Miura Y, Kasahara T, Kitamura S et al. Highly purified murine interleukin 5 (IL-5) stimulates eosinophil function and prolongs in vitro survival. IL-5 as an eosinophil chemotactic factor. J Exp Med 1988; 167: 1737-1742.
47. Kankaanranta H, Ilmarinen P, Zhang X, Adcock IM, Lahti A, Barnes PJ et al. Tumour necrosis factor-alpha regulates human eosinophil apoptosis via ligation of TNF-receptor 1 and balance between NF-kappaB and AP-1. PloS One 2014; 9: e90298.
48. Huaux F, Gharaee-Kermani M, Liu T, Morel V, McGarry B, Ullenbruch M et al. Role of Eotaxin-1 (CCL11) and CC chemokine receptor 3 (CCR3) in bleomycin-induced lung injury and fibrosis. The American journal of pathology 2005; 167: 1485-1496.
49. Sumi Y, Hamid Q. Airway remodeling in asthma. Allergol Int 2007; 56: 341-348.
50. Foster PS, Mould AW, Yang M, Mackenzie J, Mattes J, Hogan SP et al. Elemental signals regulating eosinophil accumulation in the lung. Immunol Rev 2001; 179: 173-181.
51. Lora JM, Zhang DM, Liao SM, Burwell T, King AM, Barker PA et al. Tumor necrosis factoralpha triggers mucus production in airway epithelium through an IkappaB kinase betadependent mechanism. J Biol Chem 2005; 280: 36510-36517.
52. Pinho V, Souza DG, Barsante MM, Hamer FP, De Freitas MS, Rossi AG et al. Phosphoinositide-3 kinases critically regulate the recruitment and survival of eosinophils in vivo: importance for the resolution of allergic inflammation. J Leuk Biol 2005; 77: 800-810.
53. Perez DA, Vago JP, Athayde RM, Reis AC, Teixeira MM, Sousa LP et al. Switching off key signaling survival molecules to switch on the resolution of inflammation. Mediators Inflamm 2014; 2014: 829851.
54. Pollock JD,Williams DA, Gifford MA, Li LL, Du X, Fisherman J et al. Mouse model of X-linked chronic granulomatous disease, an inherited defect in phagocyte superoxide production. Nat Genet 1995; 9: 202-209.
55. Duffin R, Leitch AE, Sheldrake TA, Hallett JM, Meyer C, Fox S et al. The CDK inhibitor, R-roscovitine, promotes eosinophil apoptosis by down-regulation of Mcl-1. FEBS Lett 2009; 583: 2540-2546.
56. Kurowska-Stolarska M, Kewin P, Murphy G, Russo RC, Stolarski B, Garcia CC et al. IL-33 induces antigen-specific IL-5+ T cells and promotes allergic-induced airway inflammation independent of IL-4. J Immunol 2008; 181: 4780-4790.
57. Marques PE, Oliveira AG, Pereira RV, David BA, Gomides LF, Saraiva AM et al. Hepatic DNA deposition drives drug-induced liver injury and inflammation in mice. Hepatology 2014; 61: 348-360.
58. Serra MF, Anjos-Valotta EA, Olsen PC, Couto GC, Jurgilas PB, Cotias AC et al. Nebulized lidocaine prevents airway inflammation, peribronchial fibrosis, and mucus production in a murine model of asthma. Anesthesiology 2012; 117: 580-591.
59. Arantes-Costa FM, Lopes FD, Toledo AC, Magliarelli-Filho PA, Moriya HT, Carvalho-Oliveira R et al. Effects of residual oil fly ash (ROFA) in mice with chronic allergic pulmonary inflammation. Toxicol Pathol 2008; 36: 680-686.
60. Sousa LP, Carmo AF, Rezende BM, Lopes F, Silva DM, Alessandri AL et al. Cyclic AMP enhances resolution of allergic pleurisy by promoting inflammatory cell apoptosis via inhibition of PI3K/Akt and NF-kappaB. Biochem Pharmacol 2009; 78: 396-405.
61. Strath M,Warren DJ, Sanderson CJ. Detection of eosinophils using an eosinophil peroxidase assay. Its use as an assay for eosinophil differentiation factors. J Immunol Methods 1985; 83: 209-215.
62. Olsen PC, Ferreira TP, Serra MF, Farias-Filho FA, Fonseca BP, Viola JP et al. Lidocainederivative JMF2-1 prevents ovalbumin-induced airway inflammation by regulating the function and survival of T cells. Clin Exp Allergy 2011; 41: 250-259.